Arbutus Biopharma Files 8-K
Ticker: ABUS · Form: 8-K · Filed: May 7, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-filing
TL;DR
Arbutus Biopharma filed a standard 8-K on May 7, 2025.
AI Summary
Arbutus Biopharma Corporation filed an 8-K on May 7, 2025, reporting other events and financial statements. The company, formerly known as Tekmira Pharmaceuticals Corp, is incorporated in British Columbia, Canada, and its principal executive offices are located in Warminster, Pennsylvania. The filing does not disclose specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Arbutus Biopharma, providing an update on their regulatory disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain information about significant financial changes, acquisitions, or legal issues.
Key Players & Entities
- Arbutus Biopharma Corporation (company) — Registrant
- Tekmira Pharmaceuticals Corp (company) — Former company name
- May 7, 2025 (date) — Date of report
- Warminster, Pennsylvania (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Arbutus Biopharma Corporation?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of May 7, 2025.
When was Arbutus Biopharma Corporation's most recent name change?
The company was formerly known as Tekmira Pharmaceuticals Corp, with a date of name change on June 7, 2011.
Where are Arbutus Biopharma Corporation's principal executive offices located?
Arbutus Biopharma Corporation's principal executive offices are located at 701 Veterans Circle, Warminster, Pennsylvania 18974.
What is the Standard Industrial Classification (SIC) code for Arbutus Biopharma Corporation?
The Standard Industrial Classification (SIC) code for Arbutus Biopharma Corporation is 2834, which corresponds to Pharmaceutical Preparations.
What is the Commission File Number for Arbutus Biopharma Corporation?
The Commission File Number for Arbutus Biopharma Corporation is 001-34949.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Arbutus Biopharma Corp (ABUS).